Mitchell Jones - Feb 11, 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Medical Officer
Signature
/s/ Mitchell Jones
Stock symbol
PALI
Transactions as of
Feb 11, 2025
Transactions value $
$0
Form type
4
Date filed
2/13/2025, 05:58 PM
Previous filing
May 30, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Stock Option (Right to Buy) Award $0 +29K $0.00 29K Feb 11, 2025 Common Stock 29K $1.13 Direct F1
transaction PALI Restricted Stock Units Award $0 +24K $0.00 24K Feb 11, 2025 Common Stock 24K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3 The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.